NHS decision halts funding for Batten disease drug, affecting future cases
Parents of affected children in Swindon express disbelief over the decision
The news that a life-prolonging drug for Batten disease will no longer be funded by the NHS for new cases has sparked anger and disbelief among families impacted by the decision. Nine-year-old Addy from Swindon, who has been benefitting from enzyme treatment to slow the progression of this terminal condition, is among those affected by the announcement.
NICE, the body responsible for determining drug eligibility for NHS funding, cited concerns about the long-term efficacy of the treatment despite acknowledging its transformative nature. Dave, Addy's father, has voiced his deep frustration and bewilderment:
"This is the only drug in the world that treats this childhood dementia, and the UK says no. Our reaction is utter bewilderment... they won't spend the money because they believe it's not a good use of public funds."
Dave explained the extensive research, testing, and human trials that precede drug availability on the NHS, noting how setbacks in decisions can discourage future developments. He highlighted the implications of the decision on ongoing research and potential new treatments:
"If you were ever to try and bring another drug to the forefront again, you'd have to go through so many human trials again. It's the only drug that is actually working, and the UK has said no."
Families and advocates are set to approach MPs and lobby for a reconsideration of the funding decision. Plans include protest activities and engaging with pharmaceutical companies to explore potential agreements. Dave noted the challenging position facing families and researchers but expressed determination to seek new avenues for advocacy with organisations like the Batten Disease Family Association.
The decision has left families grappling with the reality of restricted access to existing treatments, prompting calls for a reassessment of priorities in health funding.
Hear all the latest news from across the UK on the hour, every hour, on Greatest Hits Radio on DAB, smartspeaker, at greatesthitsradio.co.uk, and on the Rayo app.